And just to put the icing on the cake this evening14 Feb 2021 20:13
The Pfizer BioNTech vaccine achieves 94 per cent efficacy after the second dose, according to the first major “real world” study to be published on the jab’s performance.
While promising data have been coming out of Israel for the last few weeks, the Clalit Institute for Research released results of the first detailed and controlled study yesterday (Sunday) covering 1.2 million vaccinated and non-vaccinated people.
Clalit is the country’s biggest health care provider, covering over half of Israel’s population.
The study found there was a 94 per cent decrease in the rate of symptomatic infection and a 92 per cent decrease in the rate of serious illness in those vaccinated, compared to 600,000 who were not vaccinated.
Covid is beaten it’s just a timing issue now.